Challenges in Combining Antiangiogenic Therapy With Transarterial Chemoembolization for Hepatocellular Carcinoma

BACKGROUND: The combination of systemic antiangiogenic therapy and transarterial chemoembolization (TACE) for the treatment of unresectable hepatocellular carcinoma (HCC) is the subject of several ongoing clinical trials. We present a series of patients treated with sorafenib and TACE at our institu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Haydar, Ali A., Mukherji, Deborah, Faraj, Walid, Khalifeh, Mohammad, Taslakian, Bedros, Yehia, Zeinab Abou, Temraz, Sally, Brown, Karen T., Abou-Alfa, Ghassan K., Shamseddine, Ali
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Society of Gastrointestinal Oncology 2014
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171975/
https://ncbi.nlm.nih.gov/pubmed/25276263
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge